scholarly article | Q13442814 |
P50 | author | Maria Råstam | Q4976287 |
Thomas Parling | Q56587828 | ||
Jenny Odeberg | Q89481365 | ||
Ata Ghaderi | Q40073412 | ||
P2093 | author name string | Agneta Pettersson | |
Agneta Brolund | |||
Sanna Gustafsson | |||
P2860 | cites work | Psychological treatments for binge eating disorder | Q24607133 |
The efficacy of self-help group treatment and therapist-led group treatment for binge eating disorder | Q24618496 | ||
The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication | Q24672590 | ||
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations | Q27860753 | ||
Sodium oxybate in the treatment of binge eating disorder: an open-label, prospective study | Q28275217 | ||
Web-Based Cognitive Behavioral Therapy for Female Patients With Eating Disorders: Randomized Controlled Trial | Q30488067 | ||
Bupropion for overweight women with binge-eating disorder: a randomized, double-blind, placebo-controlled trial | Q33615158 | ||
Predictors and mediators of treatment outcome in patients with binge eating disorder. | Q50893953 | ||
Grazing and loss of control related to eating: two high-risk factors following bariatric surgery. | Q51717067 | ||
Imipramine and diet counseling with psychological support in the treatment of obese binge eaters: a randomized, placebo-controlled double-blind study. | Q53927156 | ||
The efficacy of a short version of a cognitive-behavioral treatment followed by booster sessions for binge eating disorder | Q56906125 | ||
Prevalence of binge-eating disorder in obese children and adolescents seeking weight-loss treatment | Q73107512 | ||
Suicidality in eating disorders: clinical and psychological correlates | Q73555942 | ||
Binge eating disorder and obesity | Q74244885 | ||
Cognitive-behavioral self-help for binge eating disorder: a controlled effectiveness study | Q77293879 | ||
Fluvoxamine in the treatment of binge-eating disorder: a multicenter placebo-controlled, double-blind trial | Q77646689 | ||
Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled study | Q79676447 | ||
Body image interventions in cognitive-behavioural therapy of binge-eating disorder: a component analysis | Q80593203 | ||
Feasibility and acceptability of CD-ROM-based cognitive-behavioural treatment for binge-eating disorder | Q80739263 | ||
Randomised controlled trial of a guided self-help treatment on the Internet for binge eating disorder | Q84275319 | ||
Lisdexamfetamine: A Review in ADHD in Adults | Q38799006 | ||
Binge-Eating Disorder and Comorbid Conditions: Differential Diagnosis and Implications for Treatment | Q39104600 | ||
Pharmacologic Treatments for Binge-Eating Disorder | Q39104606 | ||
Psychological and Behavioral Treatments for Binge-Eating Disorder | Q39104612 | ||
Group behavioral activation for patients with severe obesity and binge eating disorder: a randomized controlled trial. | Q39121167 | ||
Binge eating in surgical weight-loss treatments. Long-term associations with weight loss, health related quality of life (HRQL), and psychopathology. | Q39625954 | ||
Evidence-based clinical guidelines for eating disorders: international comparison | Q40094799 | ||
Psychiatric comorbidity in women and men with eating disorders results from a large clinical database | Q40489169 | ||
Prevalence of binge eating disorder in obese adults seeking weight loss treatment | Q40545000 | ||
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement | Q42035537 | ||
Comparison of individual and group cognitive behavioral therapy for binge eating disorder. A randomized, three-year follow-up study | Q42876739 | ||
A double-blind, placebo-controlled trial of fluvoxamine in binge eating disorder: a high placebo response | Q44421249 | ||
Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial. | Q44559999 | ||
Comprehensive interview assessment of eating behavior 18-35 months after gastric bypass surgery for morbid obesity | Q44637883 | ||
Childhood eating disorders: British national surveillance study. | Q44762622 | ||
Psychotherapy for transdiagnostic binge eating: A randomized controlled trial of cognitive-behavioural therapy, appetite-focused cognitive-behavioural therapy, and schema therapy | Q45033344 | ||
Efficacy of cognitive behavioral therapy and fluoxetine for the treatment of binge eating disorder: a randomized double-blind placebo-controlled comparison | Q45251053 | ||
A randomized wait-list controlled pilot study of dialectical behaviour therapy guided self-help for binge eating disorder | Q45711670 | ||
Meta-analysis of the effectiveness of psychological and pharmacological treatments for binge eating disorder. | Q46032645 | ||
Lamotrigine in the treatment of binge-eating disorder with obesity: a randomized, placebo-controlled monotherapy trial | Q46055809 | ||
Cognitive behavioral therapy guided self-help and orlistat for the treatment of binge eating disorder: a randomized, double-blind, placebo-controlled trial | Q46468438 | ||
Effect of orlistat in obese patients with binge eating disorder | Q46802726 | ||
A randomized comparison of cognitive behavioral therapy and behavioral weight loss treatment for overweight individuals with binge eating disorder | Q47314606 | ||
Eating disorders and disordered eating among patients seeking non-surgical weight-loss treatment in Sweden. | Q47357033 | ||
A randomized controlled comparison of guided self-help cognitive behavioral therapy and behavioral weight loss for binge eating disorder | Q47368998 | ||
Armodafinil in binge eating disorder: a randomized, placebo-controlled trial | Q47568195 | ||
Duloxetine in the treatment of binge eating disorder with depressive disorders: a placebo-controlled trial | Q47582258 | ||
Acamprosate in the treatment of binge eating disorder: a placebo-controlled trial | Q47600161 | ||
Lisdexamfetamine dimesylate in binge eating disorder: a placebo controlled trial | Q47605378 | ||
Pharmacological approaches to the management of binge eating disorder | Q47706234 | ||
Self-compassion training for binge eating disorder: a pilot randomized controlled trial | Q48188775 | ||
Adapted motivational interviewing for women with binge eating disorder: a randomized controlled trial | Q48322605 | ||
Current and emerging drug treatments for binge eating disorder | Q33634698 | ||
Treatment of binge eating disorder in racially and ethnically diverse obese patients in primary care: randomized placebo-controlled clinical trial of self-help and medication | Q33819235 | ||
Baclofen reduces binge eating in a double-blind, placebo-controlled, crossover study | Q34033012 | ||
Which adverse effects influence the dropout rate in selective serotonin reuptake inhibitor (SSRI) treatment? Results for 50,824 patients | Q34368534 | ||
Placebo-controlled trial of sertraline in the treatment of binge eating disorder. | Q34509017 | ||
A randomized comparison of group cognitive-behavioral therapy and group interpersonal psychotherapy for the treatment of overweight individuals with binge-eating disorder. | Q34525822 | ||
Incidence, prevalence and mortality of anorexia nervosa and other eating disorders | Q34567779 | ||
A randomized, double-blind trial comparing sertraline and fluoxetine 6-month treatment in obese patients with Binge Eating Disorder | Q34593754 | ||
A transdiagnostic comparison of enhanced cognitive behaviour therapy (CBT-E) and interpersonal psychotherapy in the treatment of eating disorders. | Q34669929 | ||
High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial | Q34721870 | ||
Brief Strategic Therapy vs Cognitive Behavioral Therapy for the Inpatient and Telephone-Based Outpatient Treatment of Binge Eating Disorder: The STRATOB Randomized Controlled Clinical Trial | Q34943079 | ||
Epidemiology, health-related quality of life and economic burden of binge eating disorder: a systematic literature review | Q35148436 | ||
A double-blind, randomized pilot trial of chromium picolinate for binge eating disorder: results of the Binge Eating and Chromium (BEACh) study | Q35174979 | ||
The clinical significance of binge eating disorder | Q35193014 | ||
Binge-eating disorder diagnosis and treatment: a recap in front of DSM-5. | Q35426442 | ||
A randomized controlled trial for obesity and binge eating disorder: low-energy-density dietary counseling and cognitive-behavioral therapy | Q35571166 | ||
Rapid response in psychological treatments for binge eating disorder. | Q35655953 | ||
Cognitive-behavioral therapy, behavioral weight loss, and sequential treatment for obese patients with binge-eating disorder: a randomized controlled trial | Q35673560 | ||
Long-term efficacy of psychological treatments for binge eating disorder | Q35791610 | ||
Pharmacological treatment of binge eating disorder: update review and synthesis | Q35817318 | ||
Binge-Eating Disorder in Adults: A Systematic Review and Meta-analysis | Q36065939 | ||
12-month follow-up of fluoxetine and cognitive behavioral therapy for binge eating disorder | Q36446124 | ||
Lisdexamfetamine Dimesylate for Adults with Moderate to Severe Binge Eating Disorder: Results of Two Pivotal Phase 3 Randomized Controlled Trials | Q36690648 | ||
The prevalence and correlates of binge eating disorder in the World Health Organization World Mental Health Surveys | Q36774110 | ||
Orlistat with behavioral weight loss for obesity with versus without binge eating disorder: randomized placebo-controlled trial at a community mental health center serving educationally and economically disadvantaged Latino/as. | Q36883087 | ||
DSM-IV psychiatric disorder comorbidity and its correlates in binge eating disorder | Q36883147 | ||
Psychological treatments of binge eating disorder | Q37133040 | ||
Self-help for binge eating disorder in primary care: a randomized controlled trial with ethnically and racially diverse obese patients | Q37394090 | ||
Prevalence, incidence, impairment, and course of the proposed DSM-5 eating disorder diagnoses in an 8-year prospective community study of young women | Q37693696 | ||
Treatment of binge eating disorder | Q37958142 | ||
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of eating disorders | Q38263406 | ||
Double-blind, randomized, placebo-controlled trial of topiramate plus cognitive-behavior therapy in binge-eating disorder | Q38394564 | ||
Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial | Q38417807 | ||
Overview of the treatment of binge eating disorder | Q38643272 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | eating disorder | Q373822 |
binge eating | Q2303219 | ||
P304 | page(s) | e5113 | |
P577 | publication date | 2018-06-21 | |
P1433 | published in | PeerJ | Q2000010 |
P1476 | title | Psychological, pharmacological, and combined treatments for binge eating disorder: a systematic review and meta-analysis | |
P478 | volume | 6 |
Q93271419 | Binge Eating Disorder in Patients with Type 2 Diabetes: Diagnostic and Management Challenges |
Q92728049 | Binge eating disorder revisited: what's new, what's different, what's next |
Q97684485 | Brain white matter microstructure in obese women with binge eating disorder |
Q58738451 | Diabetes and Diet: A Patient and Dietitian's Perspective |
Q90325361 | Eating disorders |
Q97528133 | Efficacy and safety of topiramate in binge eating disorder: a systematic review and meta-analysis |
Q96689527 | Meta-analysis on the long-term effectiveness of psychological and medical treatments for binge-eating disorder |
Q59137339 | The social defeat/overcrowding murine psychosocial stress model results in a pharmacologically reversible body weight gain but not depression - related behaviours |
Search more.